Patent attorneys and trademark attorneys occupy a distinct regulatory space within the wider legal-services landscape. They are not solicitors, they are not barristers, and their professional indemnity needs reflect the particular risks that flow from prosecuting, defending and advising on intellectual property rights. The regulatory perimeter, the claims profile and the reasonable limit of indemnity for these firms all differ from mainstream legal PI, and the cover needs to be arranged accordingly.
Patent attorneys and trademark attorneys are authorised persons under the Legal Services Act 2007. The frontline regulator is the Intellectual Property Regulation Board (IPReg), which sits under the umbrella of the Chartered Institute of Patent Attorneys (CIPA) and the Chartered Institute of Trade Mark Attorneys (CITMA). IPReg maintains the registers, sets the Code of Conduct, and enforces the standards to which registered attorneys are held.
Rule 9 of the IPReg Code of Conduct requires every regulated firm to hold adequate professional indemnity insurance. The regulator does not prescribe a single sum insured for all firms in the way the SRA Minimum Terms and Conditions do for solicitors, but the practical baseline understood across the market is a limit of at least £1 million any one claim, with many firms carrying materially higher limits reflecting the value of the IP rights they handle.
The substantive statutes are the Patents Act 1977 and the Trade Marks Act 1994, together with the implementing rules and the international framework — the Paris Convention priority-date regime, the Patent Cooperation Treaty, the Madrid Protocol for trademarks, and the European Patent Convention. Deadlines under these instruments are strict and, in most cases, unforgiving. A priority date lost is generally a priority date gone; a filing missed will not be revived by an apology.
Patent-negligence allegations cluster around a handful of recurring themes. Missed filing deadlines are perhaps the most cited: national-phase entry not made by the 30-month PCT deadline, priority year expiring without a follow-on application, response to an examination report filed a day late. Priority-date claims are a category all their own — where a specification is filed after the 12-month window closes, prior art can enter the state of the art and destroy patentability. Insufficient specification is another common ground, where the drafted application does not enable a skilled person to work the invention or fails to support the claims as later amended.
Trademark work generates its own claim patterns. Clearance-search errors — failing to identify a prior mark that later blocks registration or founds an infringement action — are a familiar head of loss. Class specification mistakes, where the goods and services are drafted too narrowly or too broadly, can leave the client without the protection they thought they had paid for. Opposition procedures, both at the UK IPO and the EUIPO, involve tight windows for grounds, evidence and cooling-off periods, and a procedural slip can end an otherwise defensible position.
IP rights are long-lived. A patent granted today may be litigated in 15 years. A trademark registered now may be relied on indefinitely, subject to renewal. That long tail means run-off cover matters more here than in many other professions. On retirement, sale or closure, an attorney firm should expect to arrange run-off for a period reflecting the limitation position under section 14A of the Limitation Act 1980, which can extend the period for latent-damage claims well beyond the standard six-year contract limitation. Six years of run-off is often described as a floor; longer arrangements are common and, in some cases, prudent.
Much attorney work is international. A UK-based firm may handle US national-phase filings via US counsel, EPO prosecution in-house and Madrid designations across dozens of jurisdictions. Cross-border PI considerations follow: where can the firm be sued, does the policy respond to claims brought in US courts, are there territorial exclusions the firm needs to understand before accepting the mandate? US filings in particular carry higher damages exposure and higher defence costs, and policies underwritten with a UK footprint may need to be extended or reviewed before US work is accepted.
PI claims against patent and trademark attorneys are typically pursued in the High Court, with the Intellectual Property Enterprise Court (IPEC) available for lower-value or less complex matters and cost caps that shape the litigation economics. Specialist tribunals — the UK IPO hearing officer, the Comptroller-General, the EPO Boards of Appeal — will often have been the forum for the underlying professional act, and the PI claim in the civil court then re-litigates what should have happened at that stage.
Worked example — illustrative only, not based on any real client. A UK patent attorney is instructed on a priority filing for a mechanical invention. The 12-month Paris Convention deadline for follow-on filings falls in early 2023. The attorney diarises the date but a diary-migration error moves the reminder off the working calendar. The deadline passes. The client, alerted only when a competitor publishes similar prior art, discovers the priority date has been lost in one commercially critical jurisdiction. Patent protection in that market is no longer available on the original claims. The client sues for the value of the lost protection, pleaded at £850,000, reflecting projected licensing revenue and enforcement value. The attorney notifies the PI insurer. Priority-date claims of this kind are exactly what specialist attorney PI policies are underwritten to answer, and the insurer defends and, where liability is established, indemnifies within the limit and terms of the policy.
For related profession-specific PI notes, see the Apex guides for solicitors PI, accountants PI and IT consultants PI, each of which sets out the equivalent regulatory framework and claim profile for its own profession.
Apex Insurance Brokers Limited is authorised and regulated by the Financial Conduct Authority. Firm reference number 724952. This entry is general information, not advice on any particular policy.